[Immunological defense and virulence of the agent in experimental chronic infection].
D000818:Animals; D002701:Chloramphenicol / Q000627:therapeutic use; D002908:Chronic Disease; D004195:Disease Models, Animal; D004926:Escherichia coli / Q000472:pathogenicity*; D004927:Escherichia coli Infections / Q000188:drug therapy / Q000276:immunology* / Q000382:microbiology; D004958:Estradiol / Q000009:adverse effects; D005260:Female; D007109:Immunity / Q000187:drug effects; D008171:Lung Diseases / Q000276:immunology; D008775:Methylprednisolone / Q000009:adverse effects; D009154:Mutation; D011374:Progesterone / Q000009:adverse effects; D011704:Pyelonephritis / Q000188:drug therapy / Q000276:immunology; D051381:Rats; D014774:Virulence
D011374:Progesterone; D004958:Estradiol; D002701:Chloramphenicol; D008775:Methylprednisolone
Infektabwehr und Erregervirulenz bei experimenteller chronischer Infektion